These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15004721)

  • 1. Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study.
    Caglar-Yagci H; Unsal S; Yagci I; Dulgeroglu D; Ozel S
    Rheumatol Int; 2005 Jun; 25(5):341-4. PubMed ID: 15004721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis.
    Migliore A; Tormenta S; Martin LS; Valente C; Massafra U; Granata M; Alimonti A
    Clin Rheumatol; 2005 Jun; 24(3):285-9. PubMed ID: 15592903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up.
    Migliore A; Tormenta S; Martin Martin LS; Iannessi F; Massafra U; Carloni E; Monno D; Alimonti A; Granata M
    Clin Rheumatol; 2006 May; 25(3):389-93. PubMed ID: 16249827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice.
    Migliore A; Tormenta S; Massafra U; Bizzi E; Iannessi F; Alimonti A; Granata M
    Curr Med Res Opin; 2008 May; 24(5):1309-16. PubMed ID: 18373891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the use of intra-articular injections as a treatment for painful hip osteoarthritis: a randomized, double-blind, multicenter, parallel-group study comparing a single 6-mL injection of hylan G-F 20 with saline.
    Brander V; Skrepnik N; Petrella RJ; Jiang GL; Accomando B; Vardanyan A
    Osteoarthritis Cartilage; 2019 Jan; 27(1):59-70. PubMed ID: 30223023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hylan G-F 20 in treatment of osteoarthritis of the hip joint.
    Vad VB; Sakalkale D; Sculco TP; Wickiewicz TL
    Arch Phys Med Rehabil; 2003 Aug; 84(8):1224-6. PubMed ID: 12917864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-articular injections of hylan G-F 20 in patients with symptomatic hip osteoarthritis: an open-label, multicentre, pilot study.
    Conrozier T; Bertin P; Mathieu P; Charlot J; Bailleul F; Treves R; Vignon E; Chevalier X
    Clin Exp Rheumatol; 2003; 21(5):605-10. PubMed ID: 14611109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intra-articular treatment with Hylan G-F 20 under ultrasound guidance in hip osteoarthritis. Clinical results after 12 months follow-up].
    Migliore A; Tormenta S; Valente C; Massafra U; Martin Martin LS; Carmenini E; Bernardini A; Alimonti A
    Reumatismo; 2005; 57(1):36-43. PubMed ID: 15776145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical response to intra-articular injections of hylan G-F 20 in symptomatic hip osteoarthritis: the OMERACT-OARSI criteria applied to the results of a pilot study.
    Conrozier T; Bertin P; Bailleul F; Mathieu P; Charlot J; Vignon E; Treves R; Chevalier X
    Joint Bone Spine; 2006 Dec; 73(6):705-9. PubMed ID: 16997602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [18-month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis].
    Migliore A; Tormenta S; Massafra U; Martin Martin LS; Carloni E; Padalino C; Alimonti A; Granata M
    Reumatismo; 2006; 58(1):39-49. PubMed ID: 16639487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the efficacy of lower and higher molecular weight viscosupplementation in the treatment of hip osteoarthritis.
    Tikiz C; Unlü Z; Sener A; Efe M; Tüzün C
    Clin Rheumatol; 2005 Jun; 24(3):244-50. PubMed ID: 15647968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis?
    Conrozier T; Vignon E
    Clin Exp Rheumatol; 2005; 23(5):711-6. PubMed ID: 16173254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hip viscosupplementation under ultra-sound guidance riduces NSAID consumption in symptomatic hip osteoarthritis patients in a long follow-up. Data from Italian registry.
    Migliore A; Granata M; Tormenta S; Laganà B; Piscitelli P; Bizzi E; Massafra U; Alimonti A; Maggi C; De Chiara R; Iannessi F; Sanfilippo A; Sotera R; Scapato P; Carducci S; Persod P; Denaro S; Camminiti M; Pagano MG; Bagnato G; Iolascon G
    Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):25-34. PubMed ID: 21381497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of symptom relief after intra-articular injection of hyaluronic acid combined with sorbitol (anti-ox-vs) in symptomatic hip osteoarthritis.
    Migliore A; Massafra U; Bizzi E; Tormenta S; Cassol M; Granata M
    Int J Immunopathol Pharmacol; 2014; 27(2):245-52. PubMed ID: 25004836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilized-hyaluronic-acid in the hip joint: results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice.
    Conrozier T; Couris CM; Mathieu P; Merle-Vincent F; Piperno M; Coury F; Belin V; Tebib J; Vignon E
    Arch Orthop Trauma Surg; 2009 Jun; 129(6):843-8. PubMed ID: 19011882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of treatment with hylan G-F 20 on progression to total hip arthroplasty in patients with symptomatic hip OA: a retrospective study.
    Migliore A; Bizzi E; Massafra U; Bella A; Piscitelli P; Laganà B; Tormenta S
    Curr Med Res Opin; 2012 May; 28(5):755-60. PubMed ID: 22126424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective pilot study of painful lumbar facet joint arthropathy after intra-articular injection of hylan G-F 20.
    DePalma MJ; Ketchum JM; Queler ED; Trussell BS
    PM R; 2009 Oct; 1(10):908-15. PubMed ID: 19854419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients.
    Brocq O; Tran G; Breuil V; Grisot C; Flory P; Euller-Ziegler L
    Joint Bone Spine; 2002 Jun; 69(4):388-91. PubMed ID: 12184436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
    Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
    Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-articular hyaluronic acid injections for hip osteoarthritis.
    Letizia Mauro G; Scaturro D; Sanfilippo A; Benedetti MG
    J Biol Regul Homeost Agents; 2018; 32(5):1303-1309. PubMed ID: 30334430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.